Fig. 3From: Survivin: a unique target for tumor therapyImmunotherapy in cancer. The self-defence of tumors overweighs the anti-tumor immunity leading to clinical manifestations of cancer. The various immunotherapeutic approaches are adopted to reverse this imbalanceBack to article page